FDA recall record

Zenatane (isotretinoin) capsules, 40 mg recall — FDA D-0506-2017

Failed dissolution specifications - low dissolution results at S3 stage.

Class IIIclassification
D-0506-2017official record ID
Mar 8, 2017report date

Recall record at a glance

Official recordD-0506-2017
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmDr. Reddy's Laboratories, Inc.
Report dateMar 8, 2017
Recall initiation dateFeb 15, 2017
Quantity4032 cartons
LocationPrinceton, NJ, United States

Official product description

Zenatane (isotretinoin) capsules, 40 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By: Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India,NDC 55111-137-81

Why the product was recalled

Failed dissolution specifications - low dissolution results at S3 stage.

Distribution information

U.S. Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.